뒤로
Bright Minds Biosciences Inc. (DRUG) 수입
DRUG 주가 차트
DRUG 수입
Bright Minds Biosciences Inc.
$74.1
2.64%
$1.9
종가: Mar 25, 16:00:00 GMT-4
$74.3
0.26%
$0.2
애프터마켓: Mar 25, 20:22:19 GMT-4
Earnings FAQ
DRUG의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Bright Minds Biosciences Inc. DRUG의 지난 분기 매출 실적은 어땠나요?
Bright Minds Biosciences Inc.의 매출 추정치는 얼마인가요?
Bright Minds Biosciences Inc.의 수익 품질 점수는 얼마인가요?
Bright Minds Biosciences Inc.는 언제 수익을 보고하나요?
Bright Minds Biosciences Inc.의 예상 수익은 얼마인가요?
Bright Minds Biosciences Inc.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$72.19
시가
$73.77
일일 범위
$73.31 - $77.01
52주 범위
$23.17 - $123.75
거래량
116.5K
평균 거래량
169.0K
배당수익률
--
EPS(TTM)
-2.02
시가총액
$727.1M
Bright Minds Biosciences Inc.란 무엇인가요?
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York. The company went IPO on 2021-02-08. The firm is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.